DAWEX
8.2.2024 08:31:33 CET | Business Wire | Press release
Today marks the signature of Data4Industry-X, the trusted, secure, compliant and sovereign data exchange environment for the Industry sector, under the control of the industry. Initially addressing the automotive and power generation industry challenges, the solution Data4Industry-X aims at improving competitiveness and reducing the carbon footprint of major global industrial organizations with operations spread across multiple countries. Data4Industry-X will enable organizations to innovate and operate services on distributed data, coming from various factories, organizations or countries, while keeping control over the data produced locally and abroad.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240205958581/en/
The Trusted Data Exchange Solution for Industry (Credits: Dawex)
Supported by the French government’s France 2030 initiative and the European program Next Generation1, and with the endorsement of AIF (Alliance pour l’industrie du futur), Data4Industry-X relies on the technological and industrial expertise of Dawex, Schneider Electric, Valeo, CEA, and Prosyst to deliver a powerful response to support the Industry digital transformation and capitalize on the high potential of industrial data.
Contributing to the international Manufacturing-X initiative, Data4Industry-X is a trusted and secure data exchange solution, implementing the Gaia-X de facto standards and designed in compliance with the new European data regulations, such as the Data Act.
Addressing the Industry challenge of data exchange in decentralized manufacturing, Data4Industry-X will improve efficiency and productivity, accelerate data-driven innovation, boost competitiveness and minimize carbon footprint.
In a context of heavy digital transformation and industrial sovereignty, Data4Industry-X will contribute to improving Europe’s competitiveness to ultimately foster a compelling and sustainable Industry ecosystem by leveraging the full potential of broad cross-border, cross-company, cross-factory industrial data exchanges.
“The Industry sector is a strategic pillar to the European and global economy. Accelerating data exchange across trusted data spaces will definitely have a transformative impact on industrial organizations, driving innovation and responsible growth,” said Laurent Lafaye, Dawex co-CEO. “We are extremely happy to bring Dawex technology and expertise to the deployment of Data4Industry-X, and empower the Industry to foster a resilient and sustainable Industry ecosystem,” concluded Mr. Lafaye.
“Trusted data exchange is fundamental to driving collaboration, forging partnerships, and establishing new industrial models. Those new digital models are essentials for accelerating the transformation toward a more resilient, sustainable, and high-performing industrial eco-system. Schneider Electric takes pride in contributing with our industrial digital transformation expertise to develop Data4Industry-X as a flagship project of International Manufacturing-X,“ said Marc LAFONT, Innovation and Upstream Marketing VP, Industrial Automation Business Unit, Schneider Electric.
Romain Bruniaux, VP Industry, Valeo said: “Data4Industry-X is a collaborative trusted and secure data exchange solution, It offers amazing opportunities to speed up digitalization of our manufacturing process while drastically reducing our scope 1 & 2 CO2 direct and indirect emissions. With Data4Industry-X, Valeo will have the necessary data to support and direct its actions to meet our commitment to be carbon neutral by 2050.”
“Data4Industry-X capitalizes on national technologies that have already proved their worth in industry. Given the international state of the art in the field, with few operational tools known to date, Europe has a chance to take the lead in data exchange for Manufacturing,” said Alexandre Bounouh, Director CEA List, Carnot Institute.
“Collective intelligence, shared vision, teams’ symbiosis: the ingredients come together for the success of Data4Industry-X,” says Abdallah Asse, Prosyst CEO.
About Dawex
Dawex is the leader in data exchange solutions to distribute or share data products, with trust, for any business case. With the Dawex solution Data Exchange Platform, organizations create data ecosystems based on data marketplaces and data hubs that meet regulatory requirements, address traceability and security challenges. Awarded Technology Pioneer by the World Economic Forum, Dawex is the initiator of an international standardization program on “Trusted Data Transaction”. Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.
About Schneider Electric
Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries. We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values. www.se.com
About Valeo
As a technology company and partner to all automakers and new mobility players, Valeo is innovating to make mobility cleaner, safer and smarter. Valeo enjoys technological and industrial leadership in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group's growth drivers. Learn more: https://www.valeo.com/en/
About CEA-List
The CEA-List, based in Paris-Saclay and Grenoble, is a CEA technology research institute dedicated to intelligent digital systems. From artificial intelligence to digital trust, its research applies to a wide range of fields, from the industry of the future to digital health, contributing to the industrial competitiveness of its partners through innovation and technology transfer. CEA-List has been a "Carnot Institute" since 2006. Learn more: https://www.cea.fr/english
About Prosyst
Prosyst develops and markets innovative solutions (hardware and software) stimming from its strong commitment in Research and Development and offers global approaches for design, setup, simulation, data collect and management, diagnosis and performance, to support its customers all along the automated systems life cycle. Prosyst addresses all sectors of activity and counts among others, clients like Stellantis, Renault, SNCF, EDF, Naval Group, … Learn more: https://www.prosyst.fr/
1Supported by the European Union - Next Generation EU “France Relance” program
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240205958581/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release
Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom